Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose dexamethasone in hospitalized COVID-19 patients
IRCT20100228003449N31Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone in coronavirus pneumonia (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Improvement of patients' chief complaint, Improvement of peripheral blood oxygen saturation and 5 more. Started Sep 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20100228003449N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100228003449N31.